Federal award
MAPP BIOPHARMACEUTICAL, INC.
HDTRA114C0115
Contract
Obligated and Ceiling
- Obligated (net)
- $6,173,324.00
- Ceiling (potential value, not spending)
- $6,173,324.00
- Current value
- $6,173,324.00
- Gross positive obligations
- $6,230,057.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- MAPP BIOPHARMACEUTICAL, INC. · M9V9QTHR1H28
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- MAPP BIOPHARMACEUTICAL, INC. · M9V9QTHR1H28
- Awarding agency
- Department of War · sub-agency 9763 · office S0514A
- Funding agency
- Department of War · sub-agency 9761
- Product or service (PSC)
- AN12 · HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
- Industry (NAICS)
- 541711 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY
- PIID
- HDTRA114C0115
- Award type code
- D
- Actions
- 11 · Jun 10, 2014 to Apr 20, 2021
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History11
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Apr 20, 2021 | FY2021 | ARZ996 | M | $0.00 | — |
| Jun 21, 2019 | FY2019 | P00009 | B | −$56,733.00 | — |
| Jun 8, 2018 | FY2018 | P00008 | C | $1,200,000.00 | — |
| Feb 8, 2018 | FY2018 | P00007 | G | $200,000.00 | — |
| Oct 30, 2017 | FY2018 | P00006 | B | $0.00 | — |
| May 24, 2017 | FY2017 | P00005 | B | $0.00 | — |
| Jan 12, 2017 | FY2017 | P00004 | C | $1,128,981.00 | — |
| May 27, 2016 | FY2016 | P00003 | G | $1,128,981.00 | — |
| Nov 24, 2015 | FY2016 | P00002 | B | $0.00 | — |
| May 20, 2015 | FY2015 | P00001 | B | $0.00 | — |
| Jun 10, 2014 | FY2014 | 0 | — | $2,572,095.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.